Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2025

Feb 27, 2025

30561_dirs_2025-02-26_fc2516a7-4f81-456c-8acb-af11119fe87b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2025-02-25

Reporting Person: Oliver Bob (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-25 Common Stock M 15147 $19.28 Acquired 52161 Direct
2025-02-25 Common Stock S 18647 $37.25 Disposed 33514 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-25 Option (right to buy) $19.28 M 15147 Disposed 2030-05-30 Common Stock (15147) Direct

Footnotes

F1: Includes 32,470 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic
equivalent of one share of Common Stock.

F2: The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.